A comparative study of the ability of recombinant oncolytic adenovirus, doxorubicin and tamoxifen to inhibit the proliferation of breast cancer cells

In this study, we compared the inhibitory effects of recombinant oncolytic adenovirus (Ad‐apoptin‐hTERTp‐E1a, Ad‐VT) with that of doxorubicin (DOX), a first‐line chemotherapy drug, and tamoxifen (TAM), an endocrine therapy drug, on the proliferation of breast cancer cells. We found that Ad‐VT could...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shanzhi, Li, Zhuoxin, Li, Yiquan, Zhu, Yilong, Han, Jicheng, Li, Wenjie, Jin, Ningyi, Fang, Jinbo, Li, Xiao, Zhu, Guangze
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575116/
https://www.ncbi.nlm.nih.gov/pubmed/36148613
http://dx.doi.org/10.1111/jcmm.17549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575116/
https://www.ncbi.nlm.nih.gov/pubmed/36148613
http://dx.doi.org/10.1111/jcmm.17549

Ejemplares similares